Trial Profile
Phase II study of PTK787/ZK222584 [vatalanib] in multiple myeloma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2008
Price :
$35
*
At a glance
- Drugs Vatalanib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 19 Dec 2006 Status change
- 30 Oct 2005 New trial record.